Literature DB >> 9144996

Risk assessment of fungi reported from humans and animals.

G S de Hoog1.   

Abstract

A classification of fungi into biosafety categories is proposed, and the criteria for attribution to biosafety levels (BSL) are briefly discussed. The list differs from previous publications on this topic mainly by stressing (ecological) criteria derived from the fungi rather than host factors, and in including all species accepted in the recent medical literature.

Entities:  

Mesh：

Year:  1996        PMID： 9144996     DOI： 10.1111/j.1439-0507.1996.tb00089.x

Source DB:  PubMed          Journal:  Mycoses        ISSN： 0933-7407            Impact factor:   4.377


  19 in total

1.  Femur osteomyelitis due to a mixed fungal infection in a previously healthy man.

Authors:  M Cimerman; N Gunde-Cimerman; P Zalar; T Perkovic
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Genome-wide association analysis of clinical vs. nonclinical origin provides insights into Saccharomyces cerevisiae pathogenesis.

Authors:  L A H Muller; J E Lucas; D R Georgianna; J H McCusker
Journal:  Mol Ecol       Date:  2011-08-31       Impact factor: 6.185

3.  Determination of MICING: a new assay for assessing minimal inhibitory concentration for invasive growth.

Authors:  J Zupan; Z Tomičić; P Raspor
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-27       Impact factor: 3.267

4.  A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice.

Authors:  Tyson R Chiaro; Ray Soto; W Zac Stephens; Jason L Kubinak; Charisse Petersen; Lasha Gogokhia; Rickesha Bell; Julio C Delgado; James Cox; Warren Voth; Jessica Brown; David J Stillman; Ryan M O'Connell; Anne E Tebo; June L Round
Journal:  Sci Transl Med       Date:  2017-03-08       Impact factor: 17.956

5.  Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid.

Authors:  Katrin Ström; Jörgen Sjögren; Anders Broberg; Johan Schnürer
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

6.  Antifungal 3-hydroxy fatty acids from Lactobacillus plantarum MiLAB 14.

Authors:  Jörgen Sjögren; Jesper Magnusson; Anders Broberg; Johan Schnürer; Lennart Kenne
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

7.  Microsatellite analysis of genetic diversity among clinical and nonclinical Saccharomyces cerevisiae isolates suggests heterozygote advantage in clinical environments.

Authors:  Ludo A H Muller; John H McCusker
Journal:  Mol Ecol       Date:  2009-05-20       Impact factor: 6.185

8.  Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits.

Authors:  Trine Danø Klingberg; Urska Lesnik; Nils Arneborg; Peter Raspor; Lene Jespersen
Journal:  FEMS Yeast Res       Date:  2008-03-18       Impact factor: 2.796

9.  Assessment of microbiological contamination in the work environments of museums, archives and libraries.

Authors:  Justyna Skóra; Beata Gutarowska; Katarzyna Pielech-Przybylska; Łukasz Stępień; Katarzyna Pietrzak; Małgorzata Piotrowska; Piotr Pietrowski
Journal:  Aerobiologia (Bologna)       Date:  2015-03-15       Impact factor: 2.410

10.  Grain dust originating from organic and conventional farming as a potential source of biological agents causing respiratory diseases in farmers.

Authors:  Wioletta A Zukiewicz-Sobczak; Grażyna Cholewa; Ewelina Krasowska; Jolanta Chmielewska-Badora; Jacek Zwoliński; Paweł Sobczak
Journal:  Postepy Dermatol Alergol       Date:  2013-12-18       Impact factor: 1.837
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.